Vedic Lifesciences Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-07-2024
- Paid Up Capital ₹ 5.00 M
as on 04-07-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 81.86%
(FY 2023)
- Profit 125.33%
(FY 2023)
- Ebitda 142.12%
(FY 2023)
- Net Worth 85.85%
(FY 2023)
- Total Assets 60.78%
(FY 2023)
About Vedic Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Latha Chaudhary, Jayesh Chaudhary, and Rajesh Chaudhary serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC152187
- Company No.
152187
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vedic Lifesciences Private Limited offer?
Vedic Lifesciences Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services.
Who are the key members and board of directors at Vedic Lifesciences?
Executive Team (1)
JC
Jayesh Chaudhary
Managing DirectorAppointment Date: 24-Mar-2005
Status: Current
Board Members(2)
Financial Performance and Corporate Structure Insights of Vedic Lifesciences.
Vedic Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 81.86% increase. The company also saw a substantial improvement in profitability, with a 125.33% increase in profit. The company's net worth Soared by an impressive increase of 85.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vedic Lifesciences?
In 2023, Vedic Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Enovate Biolife Private Limited
Active
14 years 9 months Latha Chaudhary, Jayesh Chaudhary and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vedic Lifesciences?
Vedic Lifesciences has a workforce of 37 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vedic Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vedic Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
